Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.

Baazaoui, Narjes; Iqbal, Khalid

Baazaoui, Narjes; Iqbal, Khalid.

Afiliação

Baazaoui N; Biology Department, College of Sciences and Arts Muhayil Assir, King Khalid University, Abha 61421, Saudi Arabia.
Iqbal K; Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314, USA.

Biomolecules ; 12(10)2022 10 02.

Article em En | MEDLINE | ID: mdl-36291618

Assuntos

Doença de Alzheimer; Doenças Neurodegenerativas; Humanos; Doença de Alzheimer/metabolismo; Fator Neurotrófico Derivado do Encéfalo; Peptídeos beta-Amiloides/metabolismo; Fator 2 de Crescimento de Fibroblastos

Palavras-chave

Alzheimer's disease; P021; amyloid beta; neurodegeneration; neurogenesis; neuroinflammation; neuronal plasticity; neurotrophic factors; peptide-based therapeutics; synaptic deficit; tau pathology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Doença de Alzheimer Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google